CRO Technology. All existing inventions and technologies related to CRO’s eClinical processes and systems (“CRO Technology”) belong exclusively to CRO. Neither Institution nor Investigator shall have any right to use CRO Technology for any purpose except conducting the Study. This Section 5.5 survives termination of this Agreement.
CRO Technology. All existing inventions and technologies related to CRO’s clinical processes and systems belong exclusively to CRO. This Section 6.5 survives termination of this Agreement.
CRO Technology. All existing inventions and technologies related to CRO’s eClinical processes and systems (“CRO Technology”) belong exclusively to CRO. Neither Institution nor Investigator shall have any right to use CRO Technology for any purpose except conducting the Study. This Section 5.5 survives termination of this Agreement. Technologie CRO. Všechny existující vynálezy a technologie související s procesy a systémy eClinical náležejícími CRO („Technologie CRO“) náležejí výlučně CRO. Ani Poskytovatel zdravotních služeb, ani Zkoušející nebude mít žádné právo na použití Technologie CRO pro jakékoli účely, kromě provádění Studie. Tento odstavec 5.5 zůstane v platnosti i po ukončení platnosti této Smlouvy.
CRO Technology. All existing inventions and technologies related to CRO’s eClinical processes and systems belong exclusively to CRO (“CRO Technology”). All rights and interests worldwide in any discoveries, invention, know-how or other intellectual or industrial property rights, whether patentable or not, which arise during the course of this Agreement pertaining solely to CRO Technology shall vest in and remain the property of CRO. Institution shall, at CRO’s expense, execute any and all documents or other instruments and give testimony which CRO shall deem necessary to apply for and obtain patent(s) in any country or to otherwise protect CRO's interests therein. This Section 9(e) survives termination of this Agreement.
